Partnership enables Revival Health to scale U.S. domestic manufacturing capabilities of COVID-19 Rapid Tests to 15-20 million units per month, making it one of the largest domestic producers of rapid testing.
Revival Health Inc. (Revival) and Quanta Computer today announced a strategic partnership to enable U.S.-based manufacturing capabilities of millions of rapid tests for both COVID-19 (SARS-CoV-2) and blood biomarker tests.
This partnership will leverage Revival’s rapid testing platform LumiNow® and unique, end-to-end healthcare ecosystem—Move 78®, with Quanta’s manufacturing and robotics operational expertise.
Revival’s rapid test platform, LumiNow®, enables easy-to-use, lab-free, 20-minute antigen testing for COVID-19 (SARS-CoV-2). Early testing indicates excellent sensitivity in the order of cycle-time (CT) 31 which could lead to the identification of asymptomatic persons. The LumiNow® digital lateral flow test (LFT) and innovative spectral sensor delivers a unique combination of sensitivity, at-home use, and low cost. LumiNow® delivers:
- High Accuracy and Sensitivity – Innovative LFT combined with spectral sensing –quantitative verification is done by C-reactive protein (CRP) testing to concentrations as low as tens of pg./ml, which is a factor of 10x more sensitive than standard rapid-test read-out devices.
- Easy-to-use – No user interpretation – results via Bluetooth to a smartphone app – video app guidance.
- Secure – LumiNow® platform processes data in a secure medical cloud – IEC-62304 compliance, regulatory instances (CE, FDA, TGA, CFDA) and GDPR and HIPAA standards.
- Rapid, At-home Results – 20-minute results on mobile device from the comfort of your home.
“Our goal is to be largest and most automated manufacturer of lateral flows assays in the United States. Our partnership with Quanta makes that a reality,” states Vice President, Brandon Wu.
Quanta Computer, a Global Fortune 500 Company and one of the world’s leading notebook manufacturers with capabilities in cloud computing, enterprise network solutions, mobile communications products, smart home, autotronics, IoT, AI and healthcare; brings its global production capabilities and operational innovations to the partnership. With over 10 million square feet of manufacturing and operations across Asia, North America, Europe and South-East Asia; world-class R&D capabilities; and flexible EMS, ODM, OEM, JDM business models; Quanta provides unparalleled scalability and expertise for Revival to become a leader in “Made in America” testing capabilities. “Quanta is excited to bring our best-in-class manufacturing capabilities to this partnership with Revival Health, to help increase Covid-19 testing supply and contribute towards mitigating the impact of this pandemic,” states Vice President, Frank Chuang.
For more such updates and perspectives around Digital Innovation, IoT, Data Infrastructure, AI & Cybersecurity, go to AI-Techpark.com.